IndraLab

Statements

N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide inhibits JUN. 2 / 2

| 2

reach

"However, the treatment of H89 dramatically suppressed the promoter activity of Fra-1 or c-Jun induced by LMP1 in a dose dependent manner, resulting in their decreasing protein levels."

25958199

➶

reach

"Interestingly, we found that H-89 did not inhibit TPA induction of c-jun."

10535756

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide inhibits JUN. 2 / 2

INDRA sources:

Databases

Reading